Correlation Between Syrma SGS and Krebs Biochemicals
Specify exactly 2 symbols:
By analyzing existing cross correlation between Syrma SGS Technology and Krebs Biochemicals and, you can compare the effects of market volatilities on Syrma SGS and Krebs Biochemicals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syrma SGS with a short position of Krebs Biochemicals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syrma SGS and Krebs Biochemicals.
Diversification Opportunities for Syrma SGS and Krebs Biochemicals
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Syrma and Krebs is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Syrma SGS Technology and Krebs Biochemicals and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Krebs Biochemicals and and Syrma SGS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syrma SGS Technology are associated (or correlated) with Krebs Biochemicals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Krebs Biochemicals and has no effect on the direction of Syrma SGS i.e., Syrma SGS and Krebs Biochemicals go up and down completely randomly.
Pair Corralation between Syrma SGS and Krebs Biochemicals
Assuming the 90 days trading horizon Syrma SGS Technology is expected to under-perform the Krebs Biochemicals. But the stock apears to be less risky and, when comparing its historical volatility, Syrma SGS Technology is 1.29 times less risky than Krebs Biochemicals. The stock trades about -0.2 of its potential returns per unit of risk. The Krebs Biochemicals and is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 10,414 in Krebs Biochemicals and on October 30, 2024 and sell it today you would lose (775.00) from holding Krebs Biochemicals and or give up 7.44% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Syrma SGS Technology vs. Krebs Biochemicals and
Performance |
| Timeline |
| Syrma SGS Technology |
| Krebs Biochemicals and |
Syrma SGS and Krebs Biochemicals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Syrma SGS and Krebs Biochemicals
The main advantage of trading using opposite Syrma SGS and Krebs Biochemicals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syrma SGS position performs unexpectedly, Krebs Biochemicals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Krebs Biochemicals will offset losses from the drop in Krebs Biochemicals' long position.| Syrma SGS vs. HMT Limited | Syrma SGS vs. KIOCL Limited | Syrma SGS vs. Punjab Sind Bank | Syrma SGS vs. ITI Limited |
| Krebs Biochemicals vs. Gangotri Textiles Limited | Krebs Biochemicals vs. Hemisphere Properties India | Krebs Biochemicals vs. Kingfa Science Technology | Krebs Biochemicals vs. Rico Auto Industries |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |